keyboard_arrow_up

New report sheds light on the Global Diabetes Drugs Industry, 2015

Global Diabetes Drugs Industry Report 2015 ‚Äčis a new market research publication announced by Reportstack. This report is a professional and in-depth study on the current state of the diabetes drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The diabetes drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Diabetes drugs industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

To access full report with TOC, please visit Global Diabetes Drugs Industry Report 2015

The report focuses on seventeen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The diabetes drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

Snapshot of TOC with Companies Mentioned

Chapter Five Major Companies Diabetes Drugs Market Status and Analysis 88

5.1 Novo Nordisk 88
5.1.1 Company Profile 88
5.1.2 Product Introduction 89
5.1.3 2010-2015 Novo Nordisk Diabetes Drugs Product Revenue Key Data 90
5.1.4 Novo Nordisk Contact Information 91
5.2 Sanofi 91
5.2.1 Company Profile 92
5.2.2 Product Introduction 93
5.2.3 2010-2015 Sanofi Diabetes Drugs Product Revenue Key Data 93
5.2.4 Sanofi Contact Information 95
5.3 MSD 95
5.3.1 Company Profile 95
5.3.2 Product Introduction 96
5.3.3 2010-2015 MSD Diabetes Drugs Product Revenue Key Data 96
5.3.4 MSD Contact Information 98
5.4 Eli Lilly 98
5.4.1 Company Profile 98
5.4.2 Product Introduction 99
5.4.3 2010-2015 Eli Lilly Diabetes Drugs Product Revenue Key Data 101
5.4.4 Eli Lilly Contact Information 102
5.5 Medtronic 102
5.5.1 Company Profile 103
5.5.2 Product Introduction 103
5.5.3 2010-2015 Medtronic Diabetes Drugs Product Revenue Key Data 107
5.5.4 Medtronic Contact Information 109
5.6 Novartis 109
5.6.1 Company Profile 109
5.6.2 Product Introduction 110
5.6.3 2010-2015 Novartis Diabetes Drugs Product Revenue Key Data 111
5.6.4 Novartis Contact Information 112
5.7 ASTRAZENECA 112
5.7.1 Company Profile 112
5.7.2 Product Introduction 113
5.7.3 2010-2015 AstraZenca Diabetes Drugs Product Revenue Key Data 114
5.7.4 AstraZenca Contact Information 115
5.8 Takada 115
5.8.1 Company Profile 116
5.8.2 Product Introduction 117
5.8.3 2010-2015 Takada Diabetes Drugs Product Revenue Key Data 117
5.8.4 Takada Contact Information 119
5.9 Bristol-Myers Squibb 119
5.9.1 Company Profile 119
5.9.2 Product Introduction 120
5.9.3 2010-2015 Bristol-Myers Squibb Diabetes Drugs Product Revenue Key Data 121
5.9.4 Bristol-Myers Squibb Contact Information 122
5.10 BOEHRINGER INGELHEIM 122
5.10.1 Company Profile 123
5.10.2 Product Introduction 124
5.10.3 2010-2015 BOEHRINGER INGELHEIM Diabetes Drugs Product Revenue Key Data 124
5.10.4 BOEHRINGER INGELHEIM Contact Information 126
5.11 Insulet 126
5.11.1 Company Profile 126
5.11.2 Product Introduction 127
5.11.3 2010-2015 Insulet Diabetes Drugs Product Revenue Key Data 127
5.11.4 Insulet Contact Information 129
5.12 TANDEM 129
5.12.1 Company Profile 129
5.12.2 Product Introduction 130
5.12.3 2010-2015 TANDEM Diabetes Drugs Product Revenue Key Data 131
5.12.4 TANDEM Contact Information 132
5.13 NCPC 132
5.13.1 Company Profile 132
5.13.2 Product Introduction 133
5.13.3 2010-2015 NCPC Diabetes Drugs Product Revenue Key Data 134
5.13.4 NCPC Contact Information 135
5.14 HUADONG MEDICINE 135
5.14.1 Company Profile 136
5.14.2 Product Introduction 136
5.14.3 2010-2015 HUADONG MEDICINE Diabetes Drugs Product Revenue Key Data 136
5.14.4 HUADONG MEDICINE Contact Information 138
5.15 Dongbao 138
5.15.1 Company Profile 138
5.15.2 Product Introduction 139
5.15.3 2010-2015 Dongbao Diabetes Drugs Product Revenue Key Data 139
5.15.4 Dongbao Contact Information 141
5.16 Hisun 141
5.16.1 Company Profile 141
5.16.2 Product Introduction 141
5.16.3 2010-2015 Hisun Diabetes Drugs Product Revenue Key Data 142
5.16.4 Hisun Contact Information 143
5.17 Kelun 143
5.17.1 Company Profile 144
5.17.2 Product Introduction 148
5.17.3 2010-2015 Kelun Diabetes Drugs Product Revenue Key Data 148
5.17.4 Kelun Contact Information 150
5.18 Ginwa 150
5.18.1 Company Profile 150
5.18.2 Product Introduction 151
5.18.3 2010-2015 Ginwa Diabetes Drugs Product Revenue Key Data 151
5.18.4 Ginwa Contact Information 153
5.19 TIANAN 153
5.19.1 Company Profile 153
5.19.2 Product Introduction 153
5.19.3 2010-2015 TIANAN Diabetes Drugs Product Revenue Key Data 154
5.19.4 TIANAN Contact Information 155
5.20 JUMCAN 155
5.20.1 Company Profile 156
5.20.2 2010-2015 JUMCAN Diabetes Drugs Product Revenue Key Data 156
5.20.4 JUMCAN Contact Information 158
5.21 Baiyun Mountain 158
5.21.1 Company Profile 158
5.21.2 2010-2015 Baiyun Mountain Diabetes Drugs Product Revenue Key Data 159
5.21.3 Baiyun Mountain Contact Information 161
5.22 Yiling 161
5.22.1 Company Profile 161
5.22.2 Product Introduction 162
5.22.3 2010-2015 Yiling Diabetes Drugs Product Revenue Key Data 164
5.24.4 Yiling Contact Information 165
5.23 Wanbang 165
5.23.1 Company Profile 166
5.23.2 Product Introduction 167
5.23.3 2010-2015 Wanbang Diabetes Drugs Product Revenue Key Data 167
5.23.4 Wanbang Contact Information 169
5.24 Gan & Lee 169
5.24.1 Company Profile 169
5.24.2 Product Introduction 171
5.24.3 2010-2015 Gan & Lee Diabetes Drugs Product Revenue Key Data 172
5.24.4 Gan & Lee Contact Information 173
5.25 Taloph 173
5.25.1 Company Profile 174
5.25.2 Product Introduction 174
5.25.3 2010-2015 Taloph Diabetes Drugs Product Revenue Key Data 175
5.25.4 Taloph Contact Information 176

About Reportstack:

Reportstack is one of the leading distributors of market research reports in the world today. We host more than 200,000 research products from the world's top publication houses. These publications are distributed amongst 12 top industry verticals and 62 sub verticals, which are then further classified into 257 business categories and 5000 micro markets. The vast selection criterion provides granular data from the length and breadth of all these industries delivering Reportstack members with cutting edge research products to facilitate strategic business decisions.

Contact:

Debora White
Manager - Marketing 
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research